The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

allergene.co.il

Founded Year

1998

Stage

Seed | Dead

Total Raised

$1M

Last Raised

$1M

About Allergene

Developer of anti-inflammatory and anti-allergic drugs that prevent the secretion of inflammatory mediators from mast cells by a unique mechanism. The company's drugs will inhibit the allergic reaction at a very early stage and prevent the whole range of delayed inflammatory reactions. The company's products applications as anti-allergic drugs include treatment of asthma, conjunctivitis (allergic eye disease), rhinitis (hay fever), urticaria, inflammatory bowel diseases and certain kinds of migraine.

Allergene Headquarter Location

Katzir 2a

Ramat Gan, 52656,

Israel

972 3 5312620

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.